Home  /  Resource Library  /  Sandoz R-CHOP Combination Confirms Findings in REFLECT

Sandoz R-CHOP Combination Confirms Findings in REFLECT

EHA 2020: Results of a study examining the safety and effectiveness of rituximab biosimilar Rixathon in combination with chemotheapy for treatment of first line treatment of diffuse large b-cell lymphoma.